Hofseth Biocare ASA
OSE:HBC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hofseth Biocare ASA
Operating Income
Hofseth Biocare ASA
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hofseth Biocare ASA
OSE:HBC
|
Operating Income
-kr111.9m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
|
L
|
Lytix Biopharma AS
OSE:LYTIX
|
Operating Income
-kr95.9m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Arcticzymes Technologies ASA
OSE:AZT
|
Operating Income
kr2.8m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
Operating Income
-$28.6m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Circio Holding ASA
OSE:CRNA
|
Operating Income
-kr40m
|
CAGR 3-Years
28%
|
CAGR 5-Years
20%
|
CAGR 10-Years
0%
|
|
|
T
|
Thor Medical ASA
OSE:TRMED
|
Operating Income
-kr73.1m
|
CAGR 3-Years
45%
|
CAGR 5-Years
30%
|
CAGR 10-Years
-1%
|
|
Hofseth Biocare ASA
Glance View
Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal and currently employs 63 full-time employees. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
See Also
What is Hofseth Biocare ASA's Operating Income?
Operating Income
-111.9m
NOK
Based on the financial report for Dec 31, 2025, Hofseth Biocare ASA's Operating Income amounts to -111.9m NOK.
What is Hofseth Biocare ASA's Operating Income growth rate?
Operating Income CAGR 10Y
-2%
Over the last year, the Operating Income growth was 0%. The average annual Operating Income growth rates for Hofseth Biocare ASA have been 4% over the past three years , -4% over the past five years , and -2% over the past ten years .
